Companies
- Companies
- Browse
Companies
Aerosolization of antibodies, proteins, and peptides is just the beginning of what can be delivered by our sonic technology. Sonic LDI is an exciting new class of pulmonary delivery technology. More
Higher Education and Research Institution More
Related Reports
Market Research Reports provided by reports.iptechex.com
Feb 2007 - 10 pages - $1,295
Feb 2011 - 14 pages - $99
Jan 2011 - 12 pages - $99
Nov 2010 - 14 pages - $99
Dec 2010 - 37 pages - $1,000
Jan 2007 - 109 pages - $1,995
Feb 2011 - 16 pages - $99
Feb 2011 - 15 pages - $99
Dec 2010 - 13 pages - $99
Jan 2011 - 37 pages - $1,000
Your selection
Browse By
- Industry sector
- Animal health
- Biotech
- Diagnostic
- Drug delivery
- Medical device
- Pharmaceutical
- Therapeutic target
- Adult respiratory distress syndrome
- Allergy, respiratory
- Asthma
- Asthma, bronchospasm
- Bronchitis
- Chest disorder (other)
- Chlamydia pneumoniae
- Chronic obstructive pulmonary disease
- Cough
- Cystic fibrosis
- Dysplasia, bronchopulmonary
- Emphysema
- Granulomatous lung disease sarcoidosis
- Idiopathic respiratory distress syndrome
- Meconium aspiration syndrome
- Nasal disorder (other)
- Obstructive airway disease
- Pneumonia
- Pneumonocystis carinii lung infection
- Pseudomonas lung infection
- Respiratory disorder (other)
- Respiratory syncytial virus
- Respiratory tract infections
- Rhinitis
- Rhinovirus (common cold)
- Sinusitis
- Sleep apnea
- Throat disorder (other)
- Tuberculosis
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us